New Hybrid Aspirin Shrinks Tumors, Curbs Cancer Cell Growth The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great [...]
Could a NOSH-Aspirin-a-Day Keep Cancer Away?
- March 13, 2012
- Could a NOSH-Aspirin-a-Day Keep Cancer Away?
- Posted by innovation at 6:00 am
- No Responses
- Biotech, Breast Cancer, Cancers, Consider This, CUNY, Cutting-edge, FYI, Health, Innovation, Leukemia, Promising
- Tagged with: acs medicinal chemistry letters, aspirin, Biochemical and Biophysical Research Communications, biophysical research communications, cancer, city college researchers, colon cancer tumors, colorectal cancer, could a noshaspirinaday keep cancer away, h, human colon cancer, Hybrid Aspirin, hybrid aspirin releases, indiana university school of medicine, new hybrid aspirin, NOSH, NOSH-Aspirin-a-Day, nosh-aspirin-a-day keep cancer, sophie davis school of biomedical education, the city college